NASDAQ:MLAB Mesa Laboratories - MLAB Stock Forecast, Price & News Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. Adding Mesa Laboratories, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. $204.41 +8.11 (+4.13%) (As of 02/2/2023 12:49 PM ET) Add Compare Share Share Today's Range$196.22▼$205.4050-Day Range$161.65▼$202.2652-Week Range$114.21▼$279.60Volume49,500 shsAverage Volume81,509 shsMarket Capitalization$1.09 billionP/E RatioN/ADividend Yield0.33%Price Target$166.00 ProfileAnalyst RatingsChartCompetitorsDividendEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesSEC FilingsShort InterestSocial Media Mesa Laboratories MarketRank™ ForecastAnalyst RatingN/A0.00 Rating ScoreUpside/Downside18.3% Downside$166.00 Price TargetShort InterestBearish8.49% of Float Sold ShortDividend StrengthWeakBased on Four FactorsSustainabilityN/ANews Sentiment0.76Based on 8 Articles This WeekInsider TradingSelling Shares$1.22 M Sold Last QuarterProj. Earnings Growth1.99%From $6.52 to $6.65 Per ShareSee Full Details Hide Full Details Overall MarketRank™MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.0.91 out of 5 starsMedical Sector1024th out of 1,030 stocksProcess Control Instruments Industry11th out of 11 stocks 0.0 Analyst's Opinion Price Target Upside/DownsideAccording to analysts' consensus price target of $166.00, Mesa Laboratories has a forecasted downside of 18.3% from its current price of $203.23.Amount of Analyst CoverageMesa Laboratories has received no research coverage in the past 90 days. Previous Next 1.0 Short Interest Percentage of Shares Shorted8.49% of the float of Mesa Laboratories has been sold short.Short Interest Ratio / Days to CoverMesa Laboratories has a short interest ratio ("days to cover") of 5.5.Change versus previous monthShort interest in Mesa Laboratories has recently increased by 9.46%, indicating that investor sentiment is decreasing significantly. Previous Next 0.8 Dividend Strength Dividend YieldMesa Laboratories has a dividend yield of 0.33%, which is in the bottom 25% of all stocks that pay dividends.Dividend GrowthMesa Laboratories does not have a long track record of dividend growth.Dividend SustainabilityBased on earnings estimates, Mesa Laboratories will have a dividend payout ratio of 9.62% next year. This indicates that Mesa Laboratories will be able to sustain or increase its dividend. Previous Next N/A Sustainability and ESG Overall ESG (Environmental, Social, and Governance) ScoreThere is no current Upright™ data available for MLAB. Previous Next 2.6 News and Social Media Coverage News SentimentMesa Laboratories has a news sentiment score of 0.76. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.54 average news sentiment score of Medical companies.News Coverage This WeekMarketBeat has tracked 8 news articles for Mesa Laboratories this week, compared to 1 article on an average week.MarketBeat FollowsOnly 1 people have added Mesa Laboratories to their MarketBeat watchlist in the last 30 days. This is a decrease of 0% compared to the previous 30 days. Previous Next 2.5 Company Ownership Insider Buying vs. Insider SellingIn the past three months, Mesa Laboratories insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $1,220,815.00 in company stock.Percentage Held by InsidersOnly 5.50% of the stock of Mesa Laboratories is held by insiders.Percentage Held by Institutions93.00% of the stock of Mesa Laboratories is held by institutions. High institutional ownership can be a signal of strong market trust in this company. Previous Next 0.6 Earnings and Valuation Earnings GrowthEarnings for Mesa Laboratories are expected to grow by 1.99% in the coming year, from $6.52 to $6.65 per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Mesa Laboratories is -267.41, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Mesa Laboratories is -267.41, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioMesa Laboratories has a P/B Ratio of 2.71. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities. Previous Next See Top Rated MarketRank™ Stocks Here About Mesa Laboratories (NASDAQ:MLAB) StockMesa Laboratories, Inc. engages in the design, manufacture, and market of instruments and disposable products utilized in healthcare, pharmaceutical, food and beverage, medical device, and petrochemical industries. It operates through the following segments: Sterilization and Disinfection Control, Instruments, Continuous Monitoring, and Biopharmaceutical Development. The Sterilization and Disinfection Control segment manufactures and sells biological, cleaning, and chemical indicators. The Instrument segment designs, manufactures, and markets control instruments and disposable products used in the healthcare, pharmaceutical, food and beverage, medical device, industrial hygiene, and environmental air sampling industries. The Biopharmaceutical Development segment develops and sells automated systems for protein analysis and peptide synthesis solutions. The Continuous Monitoring segment includes development of systems used to monitor various environmental parameters. The company was founded by Luke R. Schmieder on March 26, 1982 and is headquartered in Lakewood, CO.Read More Receive MLAB Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Mesa Laboratories and its competitors with MarketBeat's FREE daily newsletter. Email Address MLAB Stock News HeadlinesFebruary 1, 2023 | finance.yahoo.comIs Mesa Laboratories (MLAB) a Growing Stock?January 30, 2023 | americanbankingnews.comMesa Laboratories (NASDAQ:MLAB) Rating Increased to Hold at StockNews.comFebruary 2, 2023 | Investor Place Media (Ad)Cash Holders STILL Aren't Taking Steps to PrepareStocks are crashing... inflation is through the roof... multiple industries are getting hit hard... Americans are fearful of what might happen to their stock portfolios right now -- and who's to blame them? But former Wall Street money manager Louis Navellier says all it takes is being on the right side of this force driving the massive divide. Take action today and watch his exclusive presentation -- absolutely free of charge -- to see how you should be prepping for this phenomenon.January 28, 2023 | americanbankingnews.comJohn Sakys Sells 2,100 Shares of Mesa Laboratories, Inc. (NASDAQ:MLAB) StockJanuary 13, 2023 | finance.yahoo.comMesa Labs (MLAB) Outpaces Stock Market Gains: What You Should KnowJanuary 11, 2023 | finance.yahoo.comIs Mesa Laboratories, Inc.'s (NASDAQ:MLAB) ROE Of 1.9% Concerning?January 9, 2023 | finance.yahoo.comMesa Labs (MLAB) Gains As Market Dips: What You Should KnowJanuary 3, 2023 | msn.comMesa Laboratories, Inc. declares $0.16 dividendFebruary 2, 2023 | Investor Place Media (Ad)Cash Holders STILL Aren't Taking Steps to PrepareStocks are crashing... inflation is through the roof... multiple industries are getting hit hard... Americans are fearful of what might happen to their stock portfolios right now -- and who's to blame them? But former Wall Street money manager Louis Navellier says all it takes is being on the right side of this force driving the massive divide. Take action today and watch his exclusive presentation -- absolutely free of charge -- to see how you should be prepping for this phenomenon.December 28, 2022 | finance.yahoo.comBull of the Day: Mesa Labs (MLAB)December 28, 2022 | finance.yahoo.comMesa Labs and Eldorado Gold have been highlighted as Zacks Bull and Bear of the DayDecember 18, 2022 | finance.yahoo.comHere’s Why Mesa Laboratories (MLAB) Declined in Q3December 16, 2022 | finance.yahoo.comMesa Laboratories, Inc. to Announce Third Quarter Results on February 6, 2023December 9, 2022 | seekingalpha.comMesa Laboratories: Recent Breakout Noted, But Looks Exhausted On Closer InspectionNovember 23, 2022 | msn.comMesa Laboratories's Return On Capital Employed InsightsNovember 23, 2022 | finance.yahoo.comEarnings Estimates Moving Higher for Mesa Labs (MLAB): Time to Buy?November 22, 2022 | markets.businessinsider.comWhy Mesa Laboratories (MLAB) Stock Is Getting Hammered TodayNovember 18, 2022 | nasdaq.comConestoga Capital Ups Stake in Mesa Laboratories (MLAB)November 17, 2022 | finance.yahoo.comMesa Labs Acquires Belyntic’s Peptide Purification BusinessNovember 8, 2022 | finance.yahoo.comMesa Laboratories Second Quarter 2023 Earnings: Beats ExpectationsNovember 4, 2022 | finance.yahoo.comMesa Laboratories, Inc. Appoints Shiraz Ladiwala as Lead Independent DirectorNovember 3, 2022 | finance.yahoo.comMesa Labs (MLAB) Q2 Earnings and Revenues Top EstimatesOctober 25, 2022 | finance.yahoo.comFurther weakness as Mesa Laboratories (NASDAQ:MLAB) drops 7.8% this week, taking one-year losses to 60%October 15, 2022 | seekingalpha.comMLAB Mesa Laboratories, Inc.September 11, 2022 | finance.yahoo.comMesa Laboratories, Inc. (NASDAQ:MLAB) Shares Could Be 39% Below Their Intrinsic Value EstimateSeptember 9, 2022 | seekingalpha.comMesa Laboratories: Softening Bottom Line Fundamentals, Fairly PricedAugust 6, 2022 | seekingalpha.comMesa Laboratories, Inc. 2023 Q1 - Results - Earnings Call PresentationSee More Headlines View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart Receive MLAB Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Mesa Laboratories and its competitors with MarketBeat's FREE daily newsletter. Email Address MLAB Company Calendar Last Earnings5/31/2021Ex-Dividend for 12/15 Dividend11/29/2022Dividend Payable12/15/2022Today2/02/2023Next Earnings (Confirmed)2/06/2023Ex-Dividend for 3/15 Dividend2/27/2023Dividend Payable3/15/2023Fiscal Year End3/31/2023Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ Industry Process control instruments Sub-IndustryElectronic Equipment & Instruments SectorMedical Current SymbolNASDAQ:MLAB CUSIP59064R10 CIK724004 Webwww.mesalabs.com Phone(303) 987-8000Fax303-987-8989Employees506Year FoundedN/APrice Target and Rating Average Stock Price Forecast$166.00 High Stock Price Forecast$166.00 Low Stock Price Forecast$166.00 Forecasted Upside/Downside-18.8%Consensus RatingN/A Rating Score (0-4)0.00 Research Coverage0 Analysts Profitability EPS (Most Recent Fiscal Year)($0.76) Trailing P/E RatioN/A Forward P/E Ratio31.35 P/E GrowthN/ANet Income$1.87 million Net Margins-1.78% Pretax Margin-1.98% Return on Equity6.71% Return on Assets3.74% Debt Debt-to-Equity Ratio0.53 Current Ratio2.80 Quick Ratio2.13 Sales & Book Value Annual Sales$184.34 million Price / Sales5.92 Cash Flow$11.82 per share Price / Cash Flow17.29 Book Value$75.07 per share Price / Book2.72Miscellaneous Outstanding Shares5,340,000Free Float5,043,000Market Cap$1.09 billion OptionableNot Optionable Beta0.70 Key ExecutivesJohn James SullivanChairmanGary M. OwensPresident, CEO, COO & DirectorJohn V. SakysCFO, Treasurer & Chief Accounting OfficerPeter JungVice President-Strategy & Corporate DevelopmentBrian ArchboldSenior Vice President-Continuous ImprovementKey CompetitorsViridian TherapeuticsNASDAQ:VRDNLeMaitre VascularNASDAQ:LMATOPKO HealthNASDAQ:OPKArcutis BiotherapeuticsNASDAQ:ARQTDocGoNASDAQ:DCGOView All CompetitorsInsiders & InstitutionsConestoga Capital Advisors LLCBought 86,648 shares on 2/1/2023Ownership: 10.764%CWM LLCBought 84 shares on 2/1/2023Ownership: 0.003%Rice Hall James & Associates LLCSold 622 shares on 1/27/2023Ownership: 0.267%Comerica BankBought 5,193 shares on 1/26/2023Ownership: 0.944%Alpha Cubed Investments LLCBought 1,300 shares on 1/25/2023Ownership: 0.024%View All Insider TransactionsView All Institutional Transactions MLAB Stock - Frequently Asked Questions What is Mesa Laboratories' stock price forecast for 2023? 0 Wall Street analysts have issued 12 month price targets for Mesa Laboratories' shares. Their MLAB share price forecasts range from $166.00 to $166.00. On average, they anticipate the company's share price to reach $166.00 in the next year. This suggests that the stock has a possible downside of 17.3%. View analysts price targets for MLAB or view top-rated stocks among Wall Street analysts. How have MLAB shares performed in 2023? Mesa Laboratories' stock was trading at $166.21 at the beginning of the year. Since then, MLAB shares have increased by 20.8% and is now trading at $200.74. View the best growth stocks for 2023 here. When is Mesa Laboratories' next earnings date? The company is scheduled to release its next quarterly earnings announcement on Monday, February 6th 2023. View our MLAB earnings forecast. How were Mesa Laboratories' earnings last quarter? Mesa Laboratories, Inc. (NASDAQ:MLAB) released its earnings results on Monday, May, 31st. The medical instruments supplier reported $0.74 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.91 by $0.17. The medical instruments supplier had revenue of $37.96 million for the quarter, compared to analysts' expectations of $34.92 million. Mesa Laboratories had a negative net margin of 1.78% and a positive trailing twelve-month return on equity of 6.71%. How often does Mesa Laboratories pay dividends? What is the dividend yield for Mesa Laboratories? Mesa Laboratories declared a quarterly dividend on Tuesday, January 3rd. Investors of record on Tuesday, February 28th will be paid a dividend of $0.16 per share on Wednesday, March 15th. This represents a $0.64 dividend on an annualized basis and a dividend yield of 0.32%. The ex-dividend date of this dividend is Monday, February 27th. Read our dividend analysis for MLAB. Is Mesa Laboratories a good dividend stock? Mesa Laboratories (NASDAQ:MLAB) pays an annual dividend of $0.64 per share and currently has a dividend yield of 0.33%. Read our dividend analysis for MLAB. What is Gary Owens' approval rating as Mesa Laboratories' CEO? 5 employees have rated Mesa Laboratories Chief Executive Officer Gary Owens on Glassdoor.com. Gary Owens has an approval rating of 51% among the company's employees. This puts Gary Owens in the bottom 25% of approval ratings compared to other CEOs of publicly-traded companies. What other stocks do shareholders of Mesa Laboratories own? Based on aggregate information from My MarketBeat watchlists, some companies that other Mesa Laboratories investors own include NVIDIA (NVDA), Verizon Communications (VZ), Intel (INTC), Alibaba Group (BABA), Altria Group (MO), Micron Technology (MU), Exxon Mobil (XOM), AbbVie (ABBV), Advanced Micro Devices (AMD) and Becton, Dickinson and (BDX). What is Mesa Laboratories' stock symbol? Mesa Laboratories trades on the NASDAQ under the ticker symbol "MLAB." Who are Mesa Laboratories' major shareholders? Mesa Laboratories' stock is owned by a variety of retail and institutional investors. Top institutional shareholders include Conestoga Capital Advisors LLC (10.76%), Comerica Bank (0.94%), Rice Hall James & Associates LLC (0.27%), Moody Aldrich Partners LLC (0.21%), Yousif Capital Management LLC (0.06%) and Exchange Traded Concepts LLC (0.06%). Insiders that own company stock include Brian David Archbold, David M Kelly, Evan Guillemin, Gary M Owens, Gregory Dinoia, John Bradley Schmieder, John James Sullivan, John Sakys, Robert V Dwyer and Shannon Hall. View institutional ownership trends. How do I buy shares of Mesa Laboratories? Shares of MLAB stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. Compare Top Brokerages Here. What is Mesa Laboratories' stock price today? One share of MLAB stock can currently be purchased for approximately $200.74. How much money does Mesa Laboratories make? Mesa Laboratories (NASDAQ:MLAB) has a market capitalization of $1.07 billion and generates $184.34 million in revenue each year. The medical instruments supplier earns $1.87 million in net income (profit) each year or ($0.76) on an earnings per share basis. How many employees does Mesa Laboratories have? The company employs 506 workers across the globe. How can I contact Mesa Laboratories? Mesa Laboratories' mailing address is 12100 W 6TH AVE, LAKEWOOD CO, 80228. The official website for the company is www.mesalabs.com. The medical instruments supplier can be reached via phone at (303) 987-8000, via email at investorrelations@mesalabs.com, or via fax at 303-987-8989. This page (NASDAQ:MLAB) was last updated on 2/2/2023 by MarketBeat.com Staff Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.